SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Scavo Robert L.

(Last)

(First)

(Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE

92868

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/20/2023

3. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Information Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	366,573⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options (Right to Buy)	⁽²⁾	03/25/2031	Common Stock	325,833	$18	D
Options (Right to Buy)	⁽³⁾	03/08/2032	Common Stock	36,496	$9.06	D

Explanation of Responses:

1. Includes (i) 81,504 shares of Common Stock of Alignment Healthcare, Inc. (the "Company"); (ii) 81,503 shares of unvested restricted stock, 50% of which vest on each of September 14, 2023 and September 14, 2024; (iii) 25,875 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company ("RSUs"), granted on March 25, 2021, 25% of which vested or will vest on the first four anniversaries of the grant date; (iv) 49,669 RSUs granted on March 8, 2022, 25% of which vested or will vest on the first four anniversaries of the grant date; and (v) 136,353 RSUs granted on September 12, 2022, 50% of which will vest on or about each of the third and fourth anniversaries of the grant date. An aggregate of 8,331 shares have been sold upon vesting of RSUs in non-discretionary sale-to-cover transactions. In each case, vesting is subject to the reporting person's continued service to the Company as of the applicable vesting date.

2. Options vested or will vest 25% on each of the first four anniversaries of the March 25, 2021 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

3. Options vested or will vest 25% on each of the first four anniversaries of the March 8, 2022 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Remarks:

	/s/ Richard A. Cross, as Attorney-in-Fact, for Robert L. Scavo	05/01/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.